ZS Ph2/3 Dose-response Study in Japan

Trial Identifier: D9482C00002
Sponsor: AstraZeneca
NCTID:: NCT03127644
Start Date: June 2017
Primary Completion Date: February 2018
Study Completion Date: February 2018
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Japanese Translation

Trial Locations

Country Location
Japan Chiba-shi, Japan, 263-0043
Japan Chiba-shi, Japan, 260-8712
Japan Hanyu-shi, Japan, 348-8505
Japan Higashiibaraki-gun, Japan, 311-3193
Japan Hitachinaka-shi, Japan, 312-0057
Japan Ina-shi, Japan, 396-8555
Japan Kagoshima-shi, Japan, 892-8580
Japan Kahoku-gun, Japan, 920-0293
Japan Kamakura-shi, Japan, 247-8533
Japan Kanazawa-shi, Japan, 920-8650
Japan Kasugai-shi, Japan, 486-8510
Japan Kawachinagano-shi, Japan, 586-8521
Japan Kawasaki-shi, Japan, 216-8511
Japan Kitakyushu-shi, Japan, 802-0001
Japan Koga-shi, Japan, 306-0041
Japan Kusatsu-shi, Japan, 525-8585
Japan Matsudo-shi, Japan, 271-0077
Japan Matsuyama-shi, Japan, 791-8026
Japan Nagoya-shi, Japan, 457-8511
Japan Naka-shi, Japan, 311-0113
Japan Omura-shi, Japan, 856-8562
Japan Shimajiri-gun, Japan, 901-0493
Japan Shizuoka-shi, Japan, 421-0117
Japan Yao-shi, Japan, 581-0011
Japan Yotsukaido-shi, Japan, 284-0027